Professional
Added to YB: 2025-02-06
Pitch date: 2025-02-05
WGS [bearish]
GeneDx Holdings Corp.
-123.96%
current return
Author Info
Grizzly Research produces differentiated research insights on publicly traded companies through in-depth due diligence. Sign up for the newsletter.
Company Info
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Market Cap
$3.7B
Pitch Price
$67.65
Price Target
N/A
Dividend
N/A
EV/EBITDA
87.04
P/E
1.7K
EV/Sales
9.02
Sector
Health Care Providers and Services
Category
special_situation
Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud
WGS short: Illegal code stacking inflates revenue ~25%. Whistleblower reveals undisclosed network of counselors driving sales. Failed Centrellis AI platform misrepresented. No competitive edge per geneticists. Aggressive insider selling. Acquired for $330M, now valued at $2B. Multiple lawsuits allege fraud. DoJ targeting genetic testing fraud.
Read full article (28 min)